Chapter 15: Antimicrobial Drugs
Antimicrobial Drugs and Modern Medicine
- Definition of Antimicrobial Drugs: Therapeutic agents used to fight infections caused by various microorganisms, including bacteria, viruses, fungi, and parasites.
- Role in Modern Medicine: Antimicrobials are considered the cornerstone of modern medicine.
- Prevalence and Impact:
- According to the U.S. Centers for Disease Control and Prevention (CDC), antimicrobials are among the most commonly prescribed drugs in the U.S.
- More than prescriptions for antibiotics are written each year.
- Annually in the U.S., there are approximately infections caused by antibiotic-resistant bacteria.
- Approximately people die per year as a result of these resistant infections.
The Development and History of Antimicrobials
- Etymology:
- Antimicrobial: Derived from Greek anti (against), mikros (little), and bios (life). It refers to all agents acting against microbial organisms.
- Antibiotic: Derived from Greek anti (against) and biotikos (concerning life).
- Strict Definition of Antibiotics: Substances produced by microorganisms that act against another microorganism.
- By this definition, synthetic drugs (e.g., sulfonamides, quinolones) and semisynthetic drugs (e.g., methicillin, amoxicillin) are not technically "antibiotics," though the term is often used broadly.
- Categorization by Pathogen Target:
- Antibacterial drugs: Treat bacterial infections.
- Antiviral drugs: Target viral infections.
- Antifungal drugs: Target fungal infections.
- Antiparasitic drugs: Treat protozoan and helminthic (worm) infections.
- Historical Context:
- Before antimicrobials, routine infections like strep throat could be fatal.
- Infections were the primary cause of war-related deaths throughout most of history.
- Safe and effective antimicrobials were not developed until the century.
- Key Discoveries:
- Alexander Fleming (1928): While studying Staphylococcus aureus, he noticed a plate contaminated with mold (Penicillium species) where the bacteria were unable to grow near the mold. He determined the mold excreted a compound that inhibited bacteria, which he named penicillin.
- Mass Production: Penicillin was mass-produced by (onset of WWII) to combat streptococcal and staphylococcal infections among soldiers.
- Streptomycin: Isolated from the soil bacterium Streptomyces griseus; it was the first effective treatment against tuberculosis.
Classification and Properties of Antimicrobial Drugs
- Spectrum of Activity:
- Broad-spectrum drugs: Effective against both Gram-negative and Gram-positive bacteria. Examples: levofloxacin and ciprofloxacin.
- Narrow-spectrum drugs: Effective against a limited range of bacteria. Examples: bacitracin and vancomycin.
- Clinical Preference: Narrow-spectrum drugs are generally preferred because they cause less disruption to normal microbiota. However, their use requires identifying the specific causative pathogen.
- Mechanism of Action and Effectiveness:
- Bacteriostatic: Prevent bacteria from growing. They typically target protein synthesis and metabolic pathways.
- Bactericidal: Kill bacteria directly. They typically target cell walls, cell membranes, or nucleic acids.
- Fluctuating Properties: A drug's status as bactericidal or bacteriostatic can change based on pathogen type, dose, length of regimen, pathogen load, and route of administration.
- Drawbacks of Bactericidal Drugs: They can kill normal microbiota and may lead to a deadly spike in bacterial toxin release (e.g., LPS from Gram-negative cells).
- Origins of Drugs:
- Natural antibiotics: Naturally occurring antimicrobial compounds.
- Synthetic antimicrobials: Manufactured entirely by chemical processes.
- Semisynthetic antimicrobials: Chemical modifications of natural antibiotics (e.g., adding R groups) to enhance properties like spectrum of activity or stability.
- Example: Ampicillin and amoxicillin are derived from Penicillin G but have a broader spectrum (targeting some Gram-negative) than the original (mostly Gram-positive).
- Drug Generations:
- First-generation: Result from the first round of chemical modification.
- Later generations: Result from successive rounds of modification, typically offering expanded capabilities, increased stability, or the ability to bypass resistance mechanisms.
Drug Safety and Pharmacokinetics
- Selective Toxicity: The ability of a drug to inhibit or kill a pathogen without harming the host.
- Therapeutic Index: The ratio of the maximum tolerated (safe) dose to the minimum effective (therapeutic) dose.
- A high therapeutic index indicates a safer drug, meaning it is effective at a dose well below its toxic threshold.
- Administration Routes:
- Oral: Easiest and preferred; drugs must be stable in stomach acid and absorbable in the intestines.
- Parenteral (Injection/Infusion): Used when oral is not viable. Includes Intravenous (into vein), Intramuscular (into muscle), and Subcutaneous (under skin).
- Half-Life: The time it takes for half of a dose to be eliminated or deactivated by the body, determining administration frequency.
- Short half-life: Requires frequent dosing. Example: Penicillin V (half-life of , taken every ).
- Long half-life: Requires less frequent dosing. Example: Azithromycin (half-life up to , taken every ).
Survey of Antibacterial Drugs
Cell Wall Synthesis Inhibitors (Usually Bactericidal)
Most target the production of peptidoglycan (composed of N-acetylmuramic acid, N-acetylglucosamine, and amino acids). Drugs interfere with transpeptidation (linking peptide chains), leading to cell lysis. These are most effective during the exponential growth phase.
- Beta-Lactam Antimicrobials: Characterized by a four-sided beta-lactam ring. They bind to transpeptidase enzymes.
- Penicillins: End in "-cillin." Generally safe; common side effects include rashes and GI upset. Main concerns are allergies and resistance.
- Penicillin G: Natural; must be injected (acid-labile).
- Penicillin V: Natural; can be taken orally.
- Amoxicillin/Ampicillin: Semisynthetic; broader spectrum but susceptible to beta-lactamases.
- Cloxacillin/Oxacillin/Nafcillin/Methicillin: Developed with bulky R groups to block beta-lactamases (steric hindrance).
- MRSA/ORSA: Strains that altered transpeptidase enzymes so beta-lactams cannot bind.
- Cephalosporins: Prefix "cef-" or "ceph-." Spans five generations. Successive generations show expanded activity against Gram-negative bacteria and decreased activity against Gram-positive. Fifth-generation (e.g., ceftaroline) can treat MRSA.
- Carbapenems: Suffix "-penem." Very broad spectrum. Rise of Carbapenem-resistant Enterobacteriaceae (CRE) liked Klebsiella pneumoniae and E. coli is a major crisis.
- Monobactams: Example: Aztreonam. Narrow-spectrum.
- Penicillins: End in "-cillin." Generally safe; common side effects include rashes and GI upset. Main concerns are allergies and resistance.
- Non-Beta-Lactam Cell Wall Inhibitors:
- Glycopeptides: Examples: Vancomycin and Teicoplanin. Interfere with cell wall synthesis but lack the beta-lactam ring (not susceptible to beta-lactamases). Effective against Gram-positive organisms (MRSA, C. difficile). Side effects include "red man syndrome."
- Bacitracin: Polypeptide; effective against Gram-positive; used topically (Neosporin).
- Isoniazid: Targets mycolic acid synthesis in acid-fast bacteria (Mycobacterium tuberculosis).
Nucleic Acid Synthesis Inhibitors (Usually Bactericidal)
- Quinolones/Fluoroquinolones: Synthetic; contain fluorine. Target DNA replication enzymes (DNA gyrase and topoisomerases). Examples: Ciprofloxacin (Mycobacterium/Pseudomonas), Levofloxacin (walking pneumonia).
- Rifamycins: Example: Rifampin. Binds to RNA polymerase to inhibit transcription. Broad-spectrum; used for mycobacteria. Note: Interferes with many other drugs (BCP, BP meds).
Folic Acid Synthesis Inhibitors (Usually Bacteriostatic)
- Sulfa Drugs (Sulfonamides): Broad-spectrum. Target the metabolic pathway for folic acid production. Often used in combination (e.g., TMP/SMX - Trimethoprim-sulfamethoxazole).
Protein Synthesis Inhibitors (Usually Bacteriostatic)
Focus on prokaryotic ribosomes ().
- Binding to 50S Subunit:
- Macrolides: Examples: Erythromycin, Clarithromycin, Azithromycin. Broad-spectrum.
- Lincosamides: Example: Clindamycin.
- Phenicols: Example: Chloramphenicol. Broad-spectrum.
- Binding to 30S Subunit:
- Tetracyclines: Examples: Tetracycline, Doxycycline. Broad-spectrum. Side effects: photosensitivity, bone/teeth development issues (not for children under ), C. diff risk.
- Aminoglycosides: Suffix "-mycin" or "-micin." Examples: Neomycin (topical), Amikacin, Streptomycin, Gentamicin (IV). Narrow-spectrum (Gram-negative aerobes). Side effects: Irreversible hearing loss and nephrotoxicity.
Cell Membrane Disruptors (Usually Bactericidal)
- Polypeptide Drugs: Examples: Polymyxin B and Colistin (Polymyxin E). Narrow-spectrum (Gram-negative). Interact with lipopolysaccharide (LPS) to destabilize the outer and plasma membranes. Narrow therapeutic index; used as a last resort for multidrug-resistant infections (Pseudomonas aeruginosa, Acinetobacter baumannii).
Antiviral and Eukaryotic Antimicrobial Drugs
- Development Challenges: Difficult to target without collateral damage to host cells because the pathogens are either inside the host (viruses) or share eukaryotic structures (fungi/parasites).
- Antiviral Drugs: Classified by the stage of the viral life cycle they inhibit:
- Attachment
- Penetration
- Uncoating
- Viral replication and assembly
- Viral release
- Immune response stimulation (e.g., interferons)
- Effective only during active replication; latent viruses are hard to treat. Examples: Remdesivir (COVID-19), treatments for HIV, Herpes, Hepatitis, Influenza.
- Antifungal Drugs:
- Target fungal cell walls, plasma membranes (containing ergosterol), or nucleic acids.
- Azoles/Allylamines: Inhibit enzymes building ergosterol.
- Polyenes: Make membranes leaky (lysis). Examples: Nystatin (topical), Amphotericin B (life-threatening systemic infections).
- Echinocandins: Inhibit beta-glucan synthesis in cell walls. Example: caspofungin acetate.
- Antiprotozoan/Antihelminthic Drugs:
- Antimalarials: Target Plasmodium species. Classes include Aminoquinolines (Chloroquine), Arylaminoalcohols (Quinine), Artemisinins.
- Nonmalarial Antiprotozoans: Metronidazole (Flagyl) targets nucleic acids; effective against Toxoplasma gondii, Giardia, Trichomonas vaginalis.
- Antihelminthics: Albendazole/Mebendazole (target microtubules); Praziquantel (paralyzes flukes and tapeworms).
Assessing Antimicrobial Sensitivity
- Clinical Importance: Determination of susceptibility is essential for effective treatment and combatting the annual deaths related to resistance.
- Agar Diffusion Tests:
- Kirby-Bauer Test (Disk Diffusion): Bacterium is spread on Mueller-Hinton agar. Antibiotic-infused disks are added. A Zone of Inhibition (area of no growth) is measured in millimeters ().
- E-test: Determines susceptibility.
- Interpretation: Measured diameters are compared to a reference table to categorize results as:
- Susceptible: Drug is likely effective.
- Resistant: Drug is ineffective.
- Intermediate: Borderline/uncertain response.
Section on Case Study and Practice Data
Clinical Case: The Case of the Slapdash Self-Medication
- Explores how taking leftover antibiotics contributes to medical crises and the emergence of resistant strains.
Susceptibility Data Table (Example Results)
| Drug Name | Observed Diameter () | Resistant () | Intermediate | Susceptible () |
|---|---|---|---|---|
| Ampicillin | ||||
| Erythromycin | ||||
| Ceftriaxone | ||||
| Ciprofloxacin |
- Analysis of Data:
- The test used was the Kirby-Bauer disk diffusion test (based on zone diameter measurements).
- Based on these specific results:
- The bacterium is Susceptible to Ampicillin (), Ceftriaxone (), and Ciprofloxacin ().
- The bacterium shows Intermediate sensitivity to Erythromycin ().
- To ensure effectiveness, Erythromycin should likely be excluded from the treatment plan in favor of the "Susceptible" options.